Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
MNCHIP logo — company profile

MNCHIP

Founded 2010 China China 16 employees Series B Total: $33.00M Biotechnology, Health Care +1

General Information

Company Name MNCHIP
Founded Year 2010
Location China China
Employees 16
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with MNCHIP. To contact MNCHIP, visit mnchip.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MNCHIP compare?

A PDF of MNCHIP and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MNCHIP soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MNCHIP

MNCHIP is a provider of microfluidic devices for in-vitro diagnostics (IVD). Founded in 2010 in China, the company is dedicated to simplifying the complex process of biochemical testing and reducing medical expenses through the application of advanced microfluidic technology. MNCHIP's commitment to improving human and animal health is evidenced by their two series of medical and veterinary chemistry analyzers—Celercare® and Pointcare®. These products have received certifications including CFDA, CE, and ISO13485, meeting the registration requirements of various countries.

The company secured a CNY20.00M Series B investment on 28 July 2015, with Legend Capital as the investor. MNCHIP's presence in the Biotechnology, Health Care, and Medical Devices industries showcases its potential in the healthcare sector and its alignment with the current market trends.

Business keywords: microfluidic devices, in-vitro diagnostics, veterinary technology, biochemical testing, medical institutions, CFDA certification, CE certification, ISO13485 certification, biomedical devices, diagnostic equipment, healthcare certification, biochemical analysis

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY20.00M 1
Legend Capital
Legend Capital
28 Jul 2015
Series A CNY10.00M 1
TechWisdom Capital
TechWisdom Capital
06 Aug 2014
Angel Round CNY3.00M 2
Legend Star Fortune Venture Capital
Legend Star, Fortune Venture Capital
28 Feb 2011

MNCHIP Alternatives & Competitors

MNCHIP vs
StratifiCare™ Pte. Ltd.
StratifiCare™ Pte. Ltd. Singapore

Severe Dengue Prediction Solution | Development of quality, innovative in vitro diagnostic solutions...

Seed
9 employees
Biotechnology, Health Care
MNCHIP vs
Shenzhen Dartmon Biotechnology Co., Ltd.
Shenzhen Dartmon Biotechnology Co., Ltd. China

Expertise in Tumor Pathological Diagnostics

Series A
5 employees
Health Care, Medical Devices
MNCHIP vs
Sebia
Sebia France

A Global specialized In Vitro Diagnostic player

Private Equity
555 employees
Biotechnology, Health Care

FAQ About MNCHIP

Tianjin MNCHIP Technologies Co., Ltd is a provider of microfluidic devices in in-vitro diagnostics (IVD). MNCHIP is committed to reducing the burden of medical expenses, simplifying the complex process of biochemical testing and applying the advanced mircofluidic technology to improve human and anim...
MNCHIP was founded in 2010.
MNCHIP is headquartered in China.
MNCHIP operates in Biotechnology, Health Care and Medical Devices. Its work centres on microfluidic devices, in-vitro diagnostics, veterinary technology and biochemical testing.
MNCHIP has approximately 16 employees.
MNCHIP has completed 3 funding rounds, raising a total of $33.00M. The latest funding stage is Series B.
Top alternatives and competitors to MNCHIP include StratifiCare™ Pte. Ltd., Shenzhen Dartmon Biotechnology Co., Ltd., Sebia, Maven Biotechnologies, Ezdiatech Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MNCHIP and StratifiCare™ Pte. Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MNCHIP, https://bouncewatch.com/company/mnchip, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes